Risk Score of Kuijer et al for Bleeding During Anticoagulant Treatment for Venous Thromboembolism

Purpose: To identify the risk of bleeding during anticoagulant therapy for venous thromboembolism using the risk score of Kuijer et al.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient for the risk of bleeding from anticoagulation for venous thromboembolis?

Yes

Age of the patient

years

Gender of the patient

Male

Female

Does the patient have a malignant neoplasm?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Risk score

Which indicates

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Laboratory Tests
- Bleeding Risk Indices of van der Meer et al
- Age, Biomarkers, Clinical History (ABC) Bleeding Risk Score for Atrial Fibrillation Patient
Criteria For Diagnosis
- Criteria of Graafsma et al for Anticoagulant-Related Bleeding with a Bleeding Severity Index
Severity, Prognosis, Stage
Complications

Therapy

Drug Interactions
- Risk Score of Landefeld and Goldman for Warfarin-Associated Major Bleeding in Outpatients
Dosage Adjustments
- Risk Score of Landefeld and Goldman for Warfarin-Associated Major Bleeding in Outpatients
Failure Handling And Therapy Escalation
- Risk Factors of Walker and Jick for Bleeding During Heparin Therapy
- Bleeding Risk Model of Shireman et al for an Elderly Patient Being Treated with Warfarin

Monitoring

Response To Therapy
- Risk Score of Landefeld and Goldman for Warfarin-Associated Major Bleeding in Outpatients
- CRUSADE Bleeding Score for Predicting Major In-Hospital Bleeding in a Patient Being Treated for Non-ST-Segment Elevation Myocardial Infarction
Adverse Effects
Overdose And Reversal
- Risk Score of Landefeld and Goldman for Warfarin-Associated Major Bleeding in Outpatients
Complication Detection
- HEMORR2HAGES Score of Gage et al for Predicting Hemorrhage in a Patient with Atrial Fibrillation
- Age, Biomarkers, Clinical History (ABC) Bleeding Risk Score for Atrial Fibrillation Patient

Specialty

Hematology Oncology
Clinical Laboratory
Pharmacology, clinical

Objective

risk factors
complications
dosage adjustments
administration
failure handling and therapy escalation
response to therapy
adverse effects

ICD-10

D69 - Purpura and other haemorrhagic conditions

Info

Purpose: To identify the risk of bleeding during anticoagulant therapy for venous thromboembolism using the risk score of Kuijer et al.

Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical

Objective: risk factors, complications, dosage adjustments, administration, failure handling and therapy escalation, response to therapy, adverse effects

ICD-10: D69,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path